These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23367542)

  • 1. [What Is the effect of metformin combined to chemotherapy in stage IV colorectal cancer with diabetes?].
    Jung JT
    Korean J Gastroenterol; 2012 Dec; 60(6):343-4. PubMed ID: 23367542
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes].
    Lee DJ; Kim B; Lee JH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Korean J Gastroenterol; 2012 Dec; 60(6):355-61. PubMed ID: 23242018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
    Fransgaard T; Thygesen LC; Gögenur I
    Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as an addition to conventional chemotherapy in breast cancer.
    Grenader T; Goldberg A; Shavit L
    J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
    Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
    Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
    Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
    Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
    Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Weckermann D
    Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Taneja SS
    J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-oncogenic effect of metformin].
    Noto H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
    Martin M; Marais R
    J Clin Oncol; 2012 Jul; 30(21):2698-700. PubMed ID: 22565000
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
    Zanders MM; Vissers PA; van de Poll-Franse LV
    J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].
    Debry G; Laurent J
    J Med Lyon; 1966 Mar; 47(94):407-13. PubMed ID: 5909923
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
    Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
    Martínez-Castelao A; Górriz JL; Ortiz A; Navarro-González JF
    Nefrologia; 2017; 37(6):567-571. PubMed ID: 28669489
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
    Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
    Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
    [No Abstract]   [Full Text] [Related]  

  • 19. A pharmacist's perspective on metformin use and cancer outcomes.
    Ceacareanu AC
    J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
    Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
    Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.